NOV 14, 2018 7:30 AM PST

Keynote Presentation: Diagnostic Management Teams - Implementation Obstacles

Speaker
  • Professor and Chairman, Department of Pathology, University of Texas Medical Branch-Galveston
    Biography
      Dr. Michael Laposata is the Professor and Chair of the Department of Pathology at the University of Texas Medical Branch-Galveston. He received his M.D. and Ph.D. from Johns Hopkins University School of Medicine and completed a postdoctoral research fellowship and residency in Laboratory Medicine (Clinical Pathology) at Washington University School of Medicine in St. Louis. He took his first faculty position at the University of Pennsylvania School of Medicine in Philadelphia in 1985, where he was an Assistant Professor and Director of the hospital's coagulation laboratory. In 1989, he became Director of Clinical Laboratories at the Massachusetts General Hospital and was appointed to faculty in the Department of Pathology at Harvard Medical School, where he became a tenured full Professor of Pathology. Dr. Laposata joined Vanderbilt University School of Medicine in 2008 where he was the Edward and Nancy Fody Professor of Pathology, Professor of Medicine, and the Pathologist-in-Chief.

      Dr. Laposata is the recipient of 14 major teaching prizes at Harvard, the Massachusetts General Hospital, and the University of Pennsylvania School of Medicine. His recognitions include the 1989 Lindback Award, a teaching prize with competition across the entire University of Pennsylvania system; the 1998 A. Clifford Barger mentorship award from Harvard Medical School; election to the Harvard Academy of Scholars in 2002, and to the Vanderbilt University School of Medicine Academy for Excellence in Teaching in 2009; and the highest award - by vote of the graduating class - for teaching in years 1 and 2 at Harvard Medical School in 1999, 2000, and 2005. In a peer nominated survey performed by The Pathologist, an international journal reporting on the practice of pathology, the November 2015 issue identified Dr. Laposata as the most influential pathologist in the United States, and the third most influential pathologist in the world.

    Abstract

    As the diagnostic test menu has increased in size and complexity, healthcare providers are in great need of advice on appropriate test selection and result interpretation. To address this need, diagnostic management teams headed by expert lab leaders have emerged in multiple clinical areas. Despite the great clinical need for such consultative advice for large numbers of patients, diagnostic management teams have been implemented in a limited number of institutions. This presentation will address the details of the 4 main barriers to implementation. The first barrier is the modest or absent payment for this important clinical activity. The second barrier is the limited number of individuals available to provide expert advice on test selection and result interpretation. The third problem relates to the technical issues of connectivity between the laboratory expert and the healthcare provider requesting advice. Finally, the fourth major barrier is the change in culture required within our own discipline to prioritize patient care at or above specimen management. These 4 barriers will be discussed and potential solutions will be offered.


    Show Resources
    You May Also Like
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    DEC 07, 2020 9:00 AM PST
    DEC 07, 2020 9:00 AM PST
    Date: December 7, 2020 Time: 9:00am (PST), 12:00pm (EST) The simultaneous detection of biomarkers on tissue samples plays a fundamental role in the study of the tumor microenvironment. Multi...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    NOV 14, 2018 7:30 AM PST

    Keynote Presentation: Diagnostic Management Teams - Implementation Obstacles


    Specialty

    Next-Generation Sequencing

    Oncology

    Cancer Therapeutics

    Molecular Biology

    Health

    Epigenetics

    Dna

    Research And Development

    Clinical Diagnostics

    Pcr/rt-Pcr/real-Time Pcr

    Molecular Diagnostics

    Genomics

    Research

    Dna Sequencing

    University

    Geography

    North America40%

    Asia40%

    Africa20%

    Registration Source

    Website Visitors100%

    Job Title

    Clinical Laboratory Scientist25%

    Facility/Department Manager25%

    Medical Doctor/Specialist25%

    Medical Laboratory Technician25%

    Organization

    Hospital20%

    Manufacturer - Other20%

    Life Science Company20%

    Clinical Laboratory20%

    Other20%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more